1 ness that patients with SD may develop sHLH,
our objectives were to (
1) determine the frequency of de
2 Our objectives were to:
1) establish the attractiveness
3 Our objectives are to: (
1) identify stage of engagement
4 Our objective was to ablate proliferating osteoblast lin
5 Our objective was to analyze and summarize data describi
6 Our objective was to apply the exposome to children's he
7 Our objective was to ascertain whether PCSK9 inhibition
8 Here,
our objective was to assess associations between preoxyg
9 Our objective was to assess gait asymmetry (GA) and bila
10 Our objective was to assess gender disparities in child
11 Our objective was to assess long-term longitudinal traje
12 Our objective was to assess the ability of a smartphone-
13 Our objective was to assess the antipneumococcal antibod
14 Our objective was to assess the association between usua
15 Our objective was to assess the associations of blood pr
16 Our objective was to assess the causes of gastroenteriti
17 Our objective was to assess the disease-causing potentia
18 Our objective was to assess the efficacy and safety of D
19 Our objective was to assess the feasibility and accuracy
20 Our objective was to assess the host proteomic response
21 Our objective was to assess the incidence and predictors
22 Our objective was to assess the precision of delta (15)N
23 Therefore,
our objective was to assess the predictive accuracy of t
24 Our objective was to assess the risk of posttransplant c
25 Our objective was to assess the therapeutic noninferiori
26 Our objective was to assess whether exposure to mold or
27 Our objective was to assess whether older adults with ag
28 Our objectives were to assess postfortification changes
29 Our objectives were to assess the associations between t
30 Our objectives were to assess whether 1) stage of liver
31 In an era of value-based payment reform,
our objective was to better understand the economic impa
32 Here
our objective was to bridge this paradigm gap between ro
33 Our objectives were to calculate the Fragility Index of
34 Our objective was to characterize a wild-type influenza
35 Our objective was to characterize antibiotic prescribing
36 Our objective was to characterize cause-specific mortali
37 Our objective was to characterize dams with a lactation-
38 Our objective was to characterize differences in periphe
39 Our objective was to characterize genotype specific diff
40 Our objective was to characterize potential inequalities
41 Our objective was to characterize the natural bacterial
42 Our objective was to characterize the relationship betwe
43 Our objective was to compare 2 methods of deriving compa
44 Our objective was to compare beta power in the STN and G
45 Our objective was to compare cardiovascular disease outc
46 Our objective was to compare cefiderocol disk diffusion
47 Our objective was to compare fruit morphology, physico-c
48 Our objective was to compare functional and safety outco
49 Our objective was to compare outcomes of a restrictive t
50 Our objective was to compare PACN formation rate and eff
51 Our objective was to compare patient characteristics and
52 Our objective was to compare sex-specific rates of death
53 Our objective was to compare the associations of key mod
54 hen resistance exceeds 5% in the population,
our objective was to compare the impact of alternative s
55 Our objective was to compare the levels of major milk al
56 Our objective was to compare the performance of two FDA-
57 Our objective was to compare the performance of V/Q scan
58 Our objective was to compare the week 48 antiviral effic
59 As little is known in children,
our objective was to compare TL in HIV+ (cART-naive or t
60 Our objective was to conduct a systematic review and met
61 Our objective was to consider the state of the science i
62 Our objective was to create a multinational, multistakeh
63 Our objective was to create body composition reference c
64 Our objective was to create the foundation of normative
65 Our objective is to define these barriers to academic su
66 Our objective was to define an (18)F-FDG PET/MR enterogr
67 Our objective was to define the extent of P. aeruginosa
68 Our objective was to define the prevalence and clinical
69 Our objective was to define the prevalence and correlate
70 Our objective was to define whether methylated arsenic i
71 Our objective was to demonstrate how dehydrogenase activ
72 Our objective was to demonstrate that asymptomatic nasop
73 Our objective is to describe this system and to review s
74 Our objective was to describe a new technique for HBP di
75 Our objective was to describe conditional survival as le
76 Our objective was to describe how systematic TAP-CT affe
77 Our objective was to describe SABU at a population-based
78 Our objective was to describe the distribution of gender
79 Our objective was to describe the prevalence of a compre
80 Our objective was to describe this variation and its pot
81 Our objective was to describe trends and variations in I
82 Our objectives were to describe the health of spouses of
83 Our objectives were to describe the population of patien
84 Our objectives were to describe why traditional and nont
85 Our objective is to determine circulating Bone morphogen
86 Our objective was to determine at the individual patient
87 has not been thoroughly evaluated and thus,
our objective was to determine how cognitive decline dif
88 Our objective was to determine how the cervical environm
89 Our objective was to determine if escalation of commitme
90 Our objective was to determine if pNPWT allows preventin
91 Our objective was to determine if the tendons of kangaro
92 Our objective was to determine patient-reported barriers
93 Our objective was to determine relationships between the
94 Our objective was to determine the association between m
95 Our objective was to determine the causes of optimistic
96 Our objective was to determine the diagnostic capabiliti
97 Our objective was to determine the expression pattern an
98 Our objective was to determine the frequency of noncompl
99 Our objective was to determine the genetic defect in a f
100 Our objective was to determine the impact and cost-effec
101 Our objective was to determine the impact of reduced nut
102 Our objective was to determine the impact of total prein
103 Our objective was to determine the optimal approach for
104 Our objective was to determine the outcomes of patients
105 Our objective was to determine the pathologic changes th
106 Our objective was to determine the prevalence of penile
107 Our objective was to determine the relative benefit for
108 Our objective was to determine the risk of DSA developme
109 Our objective was to determine the taxonomic structure o
110 , direct-acting antiviral therapies for HCV,
our objective was to determine whether chronic inflammat
111 Our objective was to determine whether higher systemic a
112 Our objective was to determine whether maternal urinary
113 Our objective was to determine whether patients with OHC
114 Our objective was to determine whether there is a declin
115 valence of asthma in the New York City area,
our objective was to determine whether underlying asthma
116 Thus,
our objectives were to determine and compare levels of g
117 Our objectives were to determine if randomization succes
118 Our objectives were to determine molar absorptivities (e
119 Our objectives were to determine the extent to which sur
120 Our objectives were to determine the latest VI prevalenc
121 Our objectives were to determine the NP dose effect and
122 Our objectives were to determine: 1)the proportion scree
123 Our objective is to develop and use a computational meth
124 Our objective is to develop optical enhancers which can
125 Therefore,
our objective was to develop a comprehensive atlas of th
126 Our objective was to develop a comprehensive MRI techniq
127 Our objective was to develop a mouse model in which anti
128 Our objective was to develop a novel approach to generat
129 Our objective was to develop a novel women's empowerment
130 Our objective was to develop a practical prediction rule
131 Our objective was to develop a rapid biomarker-based met
132 Our objective was to develop a simple method for estimat
133 Therefore,
our objective was to develop a tick transmission model o
134 Our objective was to develop and validate a prognostic s
135 Our objective was to develop and validate a SCD risk pre
136 Our objective was to develop macaque trophoblast stem ce
137 Our objective was to develop methods targeting the nanos
138 Our objectives were to develop a longitudinal mixture mo
139 Our objective was to discover a novel enhancer of ligand
140 Our objectives are to discuss the literature regarding t
141 Our objective was to engender synthetic lethality to pac
142 Our objective was to establish a two-step generic protoc
143 Our objective was to establish the safety and efficacy o
144 Our objective was to estimate global access to handwashi
145 Our objective was to estimate its average effect on plas
146 Our objective was to estimate out-of-pocket costs in the
147 Our objective was to estimate the association between pr
148 Our objective was to estimate the average global inciden
149 Our objective was to estimate the DALY after adult nontr
150 Our objective was to estimate the excess costs of asthma
151 Our objective was to estimate the monthly probabilities
152 Our objectives were to estimate the association between
153 Our objectives were to estimate the prevalence of late-s
154 Our objective was to evaluate an alternative strategy fo
155 Our objective was to evaluate associations between ATV o
156 Our objective was to evaluate how use of these treatment
157 Our objective was to evaluate minimal residual disease (
158 Our objective was to evaluate operating characteristics,
159 Our objective was to evaluate species-specific effects o
160 Our objective was to evaluate temporal trends in PBDE se
161 Our objective was to evaluate temporal trends in serum P
162 Our objective was to evaluate the accuracy of 11 phenoty
163 Our objective was to evaluate the accuracy of optic nerv
164 Our objective was to evaluate the biodistribution, kinet
165 Our objective was to evaluate the cost-effectiveness of
166 Our objective was to evaluate the diagnostic yield and a
167 Our objective was to evaluate the effect of LNS on all-c
168 Our objective was to evaluate the efficacy and safety of
169 Our objective was to evaluate the efficacy of the prenat
170 Our objective was to evaluate the expression of olfactom
171 Our objective was to evaluate the feasibility of using a
172 Our objective was to evaluate the impact of (18)F-FDG PE
173 Our objective was to evaluate the incidence rate and cum
174 Our objective was to evaluate the independent prognostic
175 Our objective was to evaluate the long-term clinical imp
176 Our objective was to evaluate the prognostic importance
177 Our objective was to evaluate three sample-to-answer mol
178 Our objectives were to evaluate the efficacy and safety
179 Our objective was to examine associations of protein int
180 Our objective was to examine inequalities in life expect
181 Our objective was to examine the association of rapid (w
182 Our objective was to examine the associations between ea
183 Our objective was to examine the effect of low- and mode
184 Our objective was to examine the effects of TRF, with or
185 Our objective was to examine the implementation and asso
186 Our objective was to examine the prevalence and impact o
187 Our objective was to examine the relation between matern
188 Our objective was to examine the relationship between sT
189 Our objective was to examine whether abnormalities in ne
190 Our objective was to examine whether individual psychoso
191 Our objective was to examine whether lactate, a metaboli
192 Our objectives were to examine associations between pote
193 Our objectives were to examine variation in age-specific
194 Our objective was to explore the kinetics of myocardial
195 Our objective was to explore the performance of risk pre
196 Our objective was to explore the safety of TPIAT in PDAC
197 Our objective was to explore the understanding and expec
198 Our objective was to explore the use of laser-capture mi
199 Our objective was to explore ways in which nurses contri
200 Our objectives were to explore the efficacy, safety, and
201 Our objectives were to explore the trends in admissions,
202 In this study,
our objective was to externally validate the natural lan
203 Our objective was to formally assess the complete respon
204 Our objective is to foster development of community-driv
205 Our objective was to further define the development of t
206 In this review,
our objective is to give a brief overview on the working
207 Our objective was to highlight patterns of diabetes-asso
208 Overall,
our objective is to identify and characterize small mole
209 Our objective is to identify metabolites associated with
210 Our objective was to identify associations between level
211 Our objective was to identify blood metabolite markers o
212 Our objective was to identify characteristics available
213 Our objective was to identify drug interactions between
214 Our objective was to identify evidence gaps and set prio
215 Our objective was to identify individual genes and gene
216 Our objective was to identify islet-derived secreted pro
217 Our objective was to identify LT-eligible patients with
218 Our objective was to identify metabolites associated wit
219 Our objective was to identify the characteristics of lip
220 In this paper,
our objective was to identify the climate signal in the
221 Our objective was to identify the effects of PPI use on
222 Our objective was to identify the transcription factors
223 Our objective was to identify variables available in a r
224 Our objective was to identify virological and serologica
225 Our objective was to identify wheat chromosomes possessi
226 Our objective was to identify, from a set of environment
227 Our objectives were to identify factors associated with
228 eastfed infants into childhood and adulthood.
Our objectives were to identify growth patterns and inve
229 Our objectives were to illuminate drivers of neonicotino
230 Our objective was to introduce (90)Y-labeled prostate-sp
231 Our objective was to investigate HF incidence and post-H
232 Our objective was to investigate longitudinal cognitive
233 Our objective was to investigate practice patterns of ca
234 In the present study,
our objective was to investigate the antidepressant effi
235 Our objective was to investigate the association of diet
236 Our objective was to investigate the associations betwee
237 Our objective was to investigate the effects of provisio
238 Our objective was to investigate the lesion detection ra
239 Our objective was to investigate the possible role of ni
240 Our objective was to investigate the potential of MRL/Mp
241 Our objective was to investigate the potential role of S
242 Our objective was to investigate whether long-term WT no
243 Our objective was to investigate whether the hazard of g
244 Our objectives were to investigate case-mix adjusted hos
245 Therefore,
our objective was to leverage on the Miami-Dade County,
246 Our objective was to longitudinally map volumetric growt
247 Our objective was to map the recurrence pattern of PCa e
248 Our objective was to measure cytology and proteome of va
249 Our objectives were to measure insulin-sensitive glucose
250 Our objective was to obtain international consensus on a
251 Our objective was to perform a comprehensive developabil
252 Our objective was to perform a systematic review to summ
253 Our objective was to predict the outcome of (90)Y radioe
254 Our objectives are to present an update with respect to
255 Our objective was to prospectively validate the use of g
256 Our objective is to provide a guide to the terminology f
257 Our objective is to provide an interface for non-bioinfo
258 Our objective was to provide experimental plausibility f
259 Our objective was to provide the first estimates of rate
260 Our objective is to quantify the impact of changes in th
261 KEY POINTS:
Our objective was to quantify endothelial function (via
262 Our objective was to quantify the rate of hyponatremia i
263 Our objective was to quantify, in a population of women
264 Our objectives were to quantify and contrast cortical fe
265 Our objectives were to quantify variation in a suite of
266 Our objective was to re-evaluate maternal iron absorptio
267 Our objective is to review pragmatic approaches to devel
268 Our objective was to review current advances in the fiel
269 Our objective was to review resistance to ART drugs and
270 Our objective was to review the literature surrounding t
271 Our objectives were to simulate changes in risks for adv
272 only examined these risks separately; thus,
our objective was to simultaneously evaluate AKI and CDI
273 Our objective was to stringently and comprehensively ass
274 Our objective was to study KTP rates among veterans list
275 Our objective was to study the association between diet
276 Our objective was to study the association between the g
277 Our objective was to study the completeness and assess t
278 Our objective was to study the mechanisms of action of f
279 Our objective was to study triptan-responsive cranial al
280 Our objective was to study variations in features before
281 Our objective was to summarize the available data and as
282 Our objective was to systematically assess the diagnosti
283 Our objective was to systematically review available lit
284 Our objective was to systematically review the biomedica
285 Our objective was to systematically review the literatur
286 Our objective was to systematically review the outcomes
287 Our objective was to test the effectiveness of the Pain
288 Our objective was to test the mitochondrially targeted a
289 Therefore,
our objectives were to test whether ICIs were associated
290 Our objective was to,
therefore, develop and validate an
291 Our objective was to trace carbon flux through pathways
292 Our objective is to understand how adult ventricular myo
293 Our objective is to understand the manner in which socio
294 Our objective is to understand the molecular determinant
295 Our objective was to understand the role of individual m
296 Our objective was to use (18)F-FDG PET/CT to identify a
297 Our objective was to use our validated VQoL instrument f
298 Our objective was to use population-level data to derive
299 Our objective was to use RMST to re-express individualiz
300 Our objective was to validate these findings in murine m